NCT06763172View on ClinicalTrials.gov

Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI

PHASE4RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
HealthyCaffeineAdenosineDopamine D2/3 Receptor Availability
Interventions
DRUG

Caffeine (200 mg)

Caffeine (200mg) will be administered per os 20 minutes prior to the PET/fMRI data acquisition.

DRUG

Placebo

Lactose tablet will be administered per os 20 minutes prior to the PET/fMRI data acquisition.

Trial Locations (1)

02129

RECRUITING

Athinoula A. Martinos Center for Biomedical Imaging, Charlestown

All Listed Sponsors
lead

Hsiao-Ying Wey

OTHER